Devdiscourse

Generative AI speeds up drug development, cutting time and costs dramatically

Bringing a single drug to market can take more than a decade and cost billions of dollars, with fewer than one in ten candidates successfully reaching approval. Against this backdrop, generative AI is ...
RAPS

Study: Most drug products recouped development costs within a decade of approval

Between 1995 and 2014, a majority of new drugs and medicines approved by the US Food and Drug Administration (FDA) recouped the average cost of drug development through net discounted sales within a ...
RAPS

Gottlieb Targets Drug Development Costs, Clinical Development Efficiencies

FDA commissioner Scott Gottlieb on Monday explained to attendees of RAPS’ Regulatory Convergence conference some steps FDA is taking to make the clinical end of drug development more efficient and ...
BioSpace

Lean Derisking: Smart Ways to Cross Drug Development’s “Valley of Death”

Nobel laureate Sir Michael Houghton and colleagues at Applied Pharmaceutical Innovation (API) outline how rigorous early ...

The blockbuster cancer drug Keytruda can cost over $150,000 | The Excerpt

Merck & Co.'s Keytruda in the U.S. starts at $12,000 for a 200 mg dose. Costs go up from there based on the insurer, provider ...

Adoption Of AI In Clinical Trials: At The Speed Of Trust

The adoption of AI in clinical trials holds the potential to revolutionize how therapies are discovered, but the pace of that ...
AOL

Drugmakers Raise Prices on 350 Medications Amid Pressure to Cut Costs

U.S. drug manufacturers are expected to raise prices on at least 350 medications in 2026. The increase coincides with pressure from the Trump administration to lower consumer costs. The detailed ...